{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:57:10Z","timestamp":1788541030112,"version":"build-2803163510"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:00:00Z","timestamp":1520467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193491","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T13:30:16Z","timestamp":1520515816000},"page":"e0193491","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4296-8867","authenticated-orcid":true,"given":"Mathieu","family":"Bastard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Sanchez-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"du Cros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atadjan Karimovich","family":"Khamraev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nargiza","family":"Parpieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirzagaleg","family":"Tillyashaykov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armen","family":"Hayrapetyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamene","family":"Kimenye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazina","family":"Khurkhumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themba","family":"Dlamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago Fadul","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Telnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Hewison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Varaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryline","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,8]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Global Tuberculosis Report [Internet]. 2016. http:\/\/apps.who.int\/medicinedocs\/documents\/s23098en\/s23098en.pdf<\/ext-link>"},{"key":"ref2","unstructured":"UNAIDS. The Gap Report [Internet]. Geneva; 2014. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_Gap_report_en.pdf<\/ext-link>"},{"key":"ref3","first-page":"1036","article-title":"Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions","volume":"17","author":"E Sanchez-Padilla","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3201\/eid1801.110850","article-title":"High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009\u20132010","volume":"18","author":"E Sanchez-Padilla","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e82235","DOI":"10.1371\/journal.pone.0082235","article-title":"Association between HIV\/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis","volume":"9","author":"YM Mesfin","year":"2014","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1183\/09031936.00205413","article-title":"HIV and multidrug-resistant tuberculosis: overlapping epidemics","volume":"44","author":"AS Dean","year":"2014","journal-title":"Eur Respir J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"969","DOI":"10.5588\/ijtld.15.0123","article-title":"Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis","volume":"19","author":"P Isaakidis","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref8","unstructured":"World Health Organization. Access to the WHO global TB database [Internet]. Geneva; 2016. http:\/\/www.who.int\/tb\/country\/data\/download\/en\/<\/ext-link>"},{"key":"ref9","unstructured":"World Health Organization. Guidelines for the Programmatic Management of Drug-resistant Tuberculosis. 2008 Emergency Update. Geneva, Switzerland. [Internet]. 2008. http:\/\/whqlibdoc.who.int\/publications\/2008\/9789241547581_eng.pdf<\/ext-link>"},{"key":"ref10","unstructured":"World Health Organization. Guidelines for the Programmatic Management of Drug-resistant Tuberculosis. 2011 Update. Geneva, Switzerland. [Internet]. 2011. http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241501583_eng.pdf<\/ext-link>"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1093\/infdis\/jis009","article-title":"Prevention, Diagnosis, and Treatment of Tuberculosis in Children and Mothers: Evidence for Action for Maternal, Neonatal, and Child Health Services","volume":"205","author":"H Getahun","year":"2012","journal-title":"J Infect Dis"},{"key":"ref12","unstructured":"World Health Organization. Global AIDS update [Internet]. 2016. http:\/\/www.who.int\/hiv\/pub\/arv\/global-AIDS-update-2016_en.pdf?ua=1<\/ext-link>"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S2352-3018(16)30190-4","article-title":"Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort study","volume":"4","author":"J Justman","year":"2017","journal-title":"Lancet HIV"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"17396","DOI":"10.7448\/IAS.15.2.17396","article-title":"HIV and tuberculosis\u2014science and implementation to turn the tide and reduce deaths","volume":"15","author":"AD Harries","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"ref15","first-page":"7","article-title":"Risk of Death among HIV Co-Infected Multidrug Resistant Tuberculosis Patients, Compared To Mortality in the General Population of South Africa","volume":"Suppl 3","author":"SO Manda","year":"2013","journal-title":"J AIDS Clin Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S1995-7645(14)60172-3","article-title":"Risk factors of treatment default and death among tuberculosis patients in a resource-limited setting","volume":"7","author":"I Alobu","year":"2014","journal-title":"Asian Pac J Trop Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e95603","DOI":"10.1371\/journal.pone.0095603","article-title":"National profile and treatment outcomes of patients with extrapulmonary tuberculosis in B\u00e9nin","volume":"9","author":"S Ade","year":"2014","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e56248","DOI":"10.1371\/journal.pone.0056248","article-title":"Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB\/HIV clinic, Malawi","volume":"8","author":"H Tweya","year":"2013","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09031936.00134712","article-title":"Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes","volume":"42","author":"D Falzon","year":"2013","journal-title":"Eur Respir J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tube.2012.06.003","article-title":"Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects","volume":"92","author":"E V Kurbatova","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e23081","DOI":"10.1371\/journal.pone.0023081","article-title":"Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection","volume":"6","author":"M Bonnet","year":"2011","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/ciu619","article-title":"Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis","volume":"59","author":"ML Bastos","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e6914","DOI":"10.1371\/journal.pone.0006914","article-title":"Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"4","author":"JC Johnston","year":"2009","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S1473-3099(13)70151-8","article-title":"Decentralisation of multidrug-resistant-tuberculosis care and management","volume":"13","author":"H Cox","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1186\/1471-2458-13-838","article-title":"TB treatment outcomes among TB-HIV co-infections in Karnataka, India: how do these compare with non-HIV tuberculosis outcomes in the province?","volume":"13","author":"S Shastri","year":"2013","journal-title":"BMC Public Health"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5588\/ijtld.13.0369","article-title":"Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study","volume":"18","author":"E Sanchez-Padilla","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jinf.2013.09.034","article-title":"Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe","volume":"68","author":"FA Post","year":"2014","journal-title":"J Infect"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tube.2012.06.003","article-title":"Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects","volume":"92","author":"E V Kurbatova","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.5588\/ijtld.13.0369","article-title":"Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: A quantitative and qualitative study","volume":"18","author":"E Sanchez-Padilla","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5588\/ijtld.13.0627","article-title":"Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial","volume":"18","author":"N Padayatchi","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5588\/ijtld.11.0473","article-title":"HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era","volume":"16","author":"E Palacios","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(10)60492-8","article-title":"Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study","volume":"375","author":"K Dheda","year":"2010","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00002030-200106150-00015","article-title":"Non-adherence to highly active antiretroviral therapy predicts progression to AIDS","volume":"15","author":"DR Bangsberg","year":"2001","journal-title":"Aids"},{"key":"ref34","article-title":"Effects of Treatment Interruption Patterns on Treatment Success Among Patients With Multidrug-Resistant Tuberculosis in Armenia and Abkhazia","author":"M Bastard","year":"2014","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/AAC.06126-11","article-title":"Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance","volume":"56","author":"AH Diacon","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1183\/09031936.00125812","article-title":"Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis","volume":"41","author":"V Skripconoka","year":"2013","journal-title":"Eur Respir J"},{"key":"ref37","unstructured":"World Health Organization. Interim guidance on the use of bedaquiline to treat MDR-TB [Internet]. 2013. http:\/\/www.who.int\/tb\/challenges\/mdr\/bedaquiline\/en\/<\/ext-link>"},{"key":"ref38","unstructured":"World Health Organization. The use of delamanid in the treatment of multidrug-resistant tuberculosis Interim policy guidance [Internet]. 2014. http:\/\/www.who.int\/tb\/publications\/delamanid-in-mdr-tb-treatment\/en\/<\/ext-link>"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/jac\/dkv447","article-title":"Drug\u2014drug interactions between bedaquiline and the antiretrovirals lopinavir\/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB","volume":"71","author":"M Pandie","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1128\/AAC.03246-14","article-title":"Impact of Lopinavir-Ritonavir or Nevirapine on Bedaquiline Exposures and Potential Implications for Patients with Tuberculosis-HIV Coinfection","volume":"58","author":"EM Svensson","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1128\/AAC.00509-16","article-title":"Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects","volume":"60","author":"S Mallikaarjun","year":"2016","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:52:50Z","timestamp":1540032770000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193491"}},"subtitle":[],"editor":[{"given":"Srinand","family":"Sreevatsan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,8]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193491","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,8]]}}}